| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/18/1994 | WO1994018562A1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |
| 08/18/1994 | WO1994018560A1 Method of assaying human tau protein, kit therefor, and diagnostic method |
| 08/18/1994 | WO1994018345A1 Receptor-binding antiproliferative peptides |
| 08/18/1994 | WO1994018332A2 Anthrax toxin fusion proteins and uses thereof |
| 08/18/1994 | WO1994018330A1 Immobilized proteins with specific binding capacities and their use in processes and products |
| 08/18/1994 | WO1994018327A1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
| 08/18/1994 | WO1994018324A2 Phospho-specific antibodies against transcription factors, more specifically against a creb derived peptide |
| 08/18/1994 | WO1994018323A1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 08/18/1994 | WO1994018322A1 HTLV-I AND HTLV-II gp21 DERIVED PEPTIDES FOR USE IN DIAGNOSTICS |
| 08/18/1994 | WO1994018318A1 Totally synthetic affinity reagents |
| 08/18/1994 | WO1994018309A1 Novel receptor-type phosphotyrosine phosphatase-gamma |
| 08/18/1994 | WO1994018308A1 Novel receptor-type phosphotyrosine phosphatase-beta |
| 08/18/1994 | WO1994018232A1 Methods for generating broadly neutralizing anti-hiv antibodies and antigens capable of eliciting same |
| 08/18/1994 | WO1994018227A2 Improved method for the refolding of proteins |
| 08/18/1994 | WO1994018221A1 Methods for producing polypeptide binding sites |
| 08/18/1994 | WO1994018220A1 Methods for producing polypeptide metal binding sites and compositions thereof |
| 08/18/1994 | WO1994018219A1 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| 08/18/1994 | WO1994017828A2 Treatment for insulin dependent diabetes |
| 08/18/1994 | WO1994014960A3 Protocadherin, their autibodies and uses |
| 08/18/1994 | WO1994011026A3 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 08/18/1994 | WO1994010203A3 Op-3-induced morphogenesis |
| 08/18/1994 | CA2155725A1 Novel receptor-type phosphotyrosine phosphatase-gamma |
| 08/18/1994 | CA2155661A1 Detection of type ii collagen and its peptides |
| 08/18/1994 | CA2155646A1 Phospho-specific antibodies against a creb derived peptide |
| 08/18/1994 | CA2155545A1 Novel receptor-type phosphotyrosine phosphatase-beta |
| 08/18/1994 | CA2155514A1 Anthrax toxin fusion proteins and uses thereof |
| 08/18/1994 | CA2155413A1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
| 08/18/1994 | CA2154266A1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |
| 08/17/1994 | EP0611228A2 Technique for extracorporeal treatment of blood |
| 08/17/1994 | EP0611080A1 Monoclonal antibody that distinguishes between phosphorylated and nonphosphorylated histone H1 |
| 08/17/1994 | EP0610729A1 Procedure for the purification of proteins and peptides from lipid-containing solutions |
| 08/17/1994 | EP0610475A1 Enzymatically-produced dimeric il-2 and a nerve-derived transglutaminase enzyme for its preparation |
| 08/17/1994 | EP0610447A1 CDw52 - SPECIFIC ANTIBODY FOR TREATMENT OF T-CELL MEDIATED INFLAMMATION OF THE JOINTS |
| 08/17/1994 | EP0610436A1 Hepatitis-c virus testing |
| 08/17/1994 | EP0610427A1 TGF-$g(b) TYPE RECEPTOR cDNAS AND USES THEREFOR |
| 08/17/1994 | EP0610335A1 Recombitope peptides |
| 08/17/1994 | EP0610330A1 Monoclonal antibodies directed against the microtubule-associated protein tau. |
| 08/17/1994 | EP0610322A1 Helicobacter pylori genes necessary for the regulation and maturation of urease, and use thereof |
| 08/17/1994 | EP0610320A1 Purified chitin deacetylase |
| 08/17/1994 | EP0610298A1 Preventing allograft rejection with antibodies to adhesion molecules |
| 08/17/1994 | EP0610290A1 Treatment of ocular inflammation by blockage of cell adhesion molecules |
| 08/17/1994 | EP0610286A1 Recombinant immunotoxins |
| 08/17/1994 | EP0610257A1 In vitro antibody perfusion of kidney grafts |
| 08/17/1994 | EP0610254A1 Glial derived neurotrophic factor |
| 08/17/1994 | EP0610211A1 Monoclonal antibodies specific for human thymidylate synthase |
| 08/17/1994 | EP0610201A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 08/17/1994 | EP0595993A4 Isolation of charged particles from fluids |
| 08/17/1994 | EP0563214A4 Bifunctional antibodies and method of preparing same |
| 08/17/1994 | EP0434727A4 Red-shifted phthalocyanine and tetrabenztriazaporphyrin reagents |
| 08/17/1994 | EP0418355B1 Process for immobilizing proteins, peptides, coenzymes, etc. on a substrate |
| 08/17/1994 | EP0265500B1 Antibody to human progesterone receptor and diagnostic materials and methods |
| 08/17/1994 | EP0248909B1 Anticytomegaloviral human monoclonal antibody and process for its preparation |
| 08/17/1994 | CN1090929A Immunoassay for isothiazolones |
| 08/17/1994 | CN1090928A Method for early detection, detection of the severity and for a treatment-accompanying assessment of the course of a sepsis, as well as a means for carrying out said method |
| 08/16/1994 | US5338850 Pyridinium derivatives |
| 08/16/1994 | US5338839 Diagnosis of brain tumors |
| 08/16/1994 | US5338836 Biologically active porcine somatotropin polypeptides and methods of using the same |
| 08/16/1994 | US5338832 Antigen recognized by MCA 16-88 |
| 08/16/1994 | US5338829 Peptides derived from human immunodeficiency virus-1 GP160 |
| 08/16/1994 | US5338671 Reduce formation of non-specific products in polymerase chain reactions |
| 08/16/1994 | US5338669 Transfecting ligated nucleic acid into eukaryotic host cell; culturing |
| 08/16/1994 | US5338661 Monoclonal antibody specific for a human tumour-associated antigen |
| 08/10/1994 | EP0610046A2 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispesific fusion proteins in a mammalian cell |
| 08/10/1994 | EP0609901A1 T-cell receptor-specific for antigen polypeptides and related polynucleotides |
| 08/10/1994 | EP0609894A2 Labeled complex and method of analysis therewith |
| 08/10/1994 | EP0609885A1 Acridinium compounds and conjugates thereof |
| 08/10/1994 | EP0609722A1 An in vitro method for detecting the presence of invasive stimuli in mammals |
| 08/10/1994 | EP0609580A1 Recombinant CMV neutralising proteins |
| 08/10/1994 | EP0609359A1 Dimorphism genes in fungi |
| 08/10/1994 | EP0500800B1 Antihemostatic factor vii peptides |
| 08/10/1994 | EP0328690B1 Method for diagnosing chronic articular rheumatism |
| 08/10/1994 | CN1090584A Synthetic polypeptides |
| 08/10/1994 | CN1090510A Interferon tau compositions and methods of use |
| 08/09/1994 | US5336782 Long chain carboxylic acid imide ester |
| 08/09/1994 | US5336760 Method and useful apparatus for preparing pharmaceutical compositions |
| 08/09/1994 | US5336618 Monoclonal antibody of the class IgG1, designated 7E3, reacts readily with both normal human and dog blood platelets while fail to react with thrombasthenic human platelets |
| 08/09/1994 | US5336610 Adsorption by immobilized HPC-4, a calcium-dependent monoclonal antibody which binds specifically to the epitope in the activation region of the heavy chain |
| 08/09/1994 | US5336603 CD4 adheson variants |
| 08/09/1994 | US5336489 Treatment of allograft rejection with IL-2 receptor-specific cytotoxins |
| 08/05/1994 | CA2114754A1 Acridinium compounds and conjugates thereof |
| 08/04/1994 | WO1994017415A1 Novel anticoagulant cofactor activity |
| 08/04/1994 | WO1994017411A1 Methods and agents for the diagnosis and treatment of rheumatoid arthritis |
| 08/04/1994 | WO1994017405A1 Assay method to rule out rupture of membranes in women at risk for imminent delivery |
| 08/04/1994 | WO1994017197A1 ANTIBODY AGAINST β-AMYLOID OR DERIVATIVE THEREOF AND USE THEREOF |
| 08/04/1994 | WO1994017193A2 Chimeric l- and p-selectin by exchange of domains - uses thereof |
| 08/04/1994 | WO1994017189A2 Protein kinases |
| 08/04/1994 | WO1994017184A1 Modulation of physiological responses of lymphocytes by cd38 or antibodies thereto |
| 08/04/1994 | WO1994017105A1 Human-murine chimeric antibodies against respiratory syncytial virus |
| 08/04/1994 | WO1994017104A1 Vaccines and methods for preventing and treating fescue toxicosis in herbivores |
| 08/04/1994 | WO1994017100A1 Icam-related protein |
| 08/04/1994 | WO1994017087A1 Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use |
| 08/04/1994 | WO1994017072A1 New biotinylation reagent |
| 08/04/1994 | WO1994016741A1 Immunoreactive reagents employing heterodimers |
| 08/04/1994 | WO1994016738A1 Antisense polynucleotide inhibition of human growth factor-sensitive cancer cells |
| 08/04/1994 | WO1994016735A1 Anti-zona pellucida antibodies for delivery of therapeutic agents to the ovary |
| 08/04/1994 | WO1994016730A1 Human monoclonal antibodies to cytomegalovirus |
| 08/04/1994 | WO1994016729A1 Targeted nitric oxide pathway or nitric oxide synthase modulation |
| 08/04/1994 | WO1994016728A1 Monoclonal anti-lfa-1 antibodies for the preparation of a medicament intended to prevent the rejection of organ transplants |
| 08/04/1994 | WO1994016726A1 Carcinoma associated antigen (ng1) monoclonal antibodies against ng1, methods of producing these antibodies and use therefor |
| 08/04/1994 | WO1994016724A1 Prevention and treatment of cytomegalovirus using aminopeptidase |